Human Unitec International, inc (OTCMKTS: HMNU) more than doubled on Wednesday after the Company reported three strategic marketing agreements for its HMNU-MSK Kinesis Medical Equipment. The three entities have agreed to an annual sale of 900 HMNU MSK Kinesis medical machines at a minimum cost of 39,000 USD each for a minimum annual revenue in excess of Thirty Million USD. The news brought some life into HMNU which was languishing at half a cent just over its $0.033 52-week lows. HMNU does have runner in its blood running to highs of $0.055 in June 2021 making a number of similar moves over the years.
HMNU has a super low float with just 881,930,000 shares outstanding, 489,246,567 of which are restricted leaving just 392,683,433 free trading shares worth under $2 million at current market levels. HMNU has $2.4 million in the treasury and $20 million in investments vs. a $21.7 million deffered note payable. For the 3 months ended March 31, the Company reported revenues of $358,000 and a net income of $98,860.00 compared to $59,860.00 for the prior quarter. The $39 million in revenues from the Company’s HMNU-MSK Kinesis Medical Equipment will augment current sales very nicely.
Human Unitec International, inc (OTCMKTS: HMNU) operating out of Hudson, NY, is a Project Finance, Management & Development Company engaged in Medical, Wellness, and Green Energy. The Company is “pink current” and listed on the US OTC Market. With support of seasoned and experienced managements the Company has evolved into an international finance and management company with a number of diversified investments and is leader in Medical & Wellness and Green Energy industries. This decision of diversified investment was based on the acquisition of activities in cooperation and joint venture with the founders and operating management of the new venture.
HMNU is a leader on the Green Energy industry as builder of a 20 tons tires and or plastic recycling plat, unique for technology and price on the global market. In 2020, the Company delivered the first innovative 20 Tons plant to Sedda Green Energy srl in Porto Torres, Italy.
HMNU is a leader on the medical industry for its MSK Kinesis Technology and protocols for pain management therapies. The therapies and the protocols have been adopted for a range of medical treatments for pain management, Parkinson disease, treatment of blood clots and thrombosis.
The Company is led by its new President, Kurt M. Gaensel, a seasoned executive who was a Business Development Manager for German Expansion Office Plastics & PCB. Contracted to relocate to Frankfurt Germany to open up an expansion office to target the European Automobile Market for Injection Molding and Printed Circuit Board business. In 2012 sales from Europe was at 8 million and by end 2017 Sales grew to 28 million. Setup business operations and develop account structure with our Inside Sales team in India and Germany. Traveled to customers, Tier 1-2 suppliers in all of Europe for meetings. Manage material procurement, Inventory Control and MRP for customers production. Oversee the Supply Chain and Logistics to ensure parts arrive in time for production.
To Find out the inside Scoop on HMNU Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

HMNU stock more than doubled on May 25 after the Company reported three strategic marketing agreements for its HMNU-MSK Kinesis Medical Equipment. On May 24, 2022, after the result of four years of corroboration, testing and equipment design, HMNU signed an agreement with Compagnia del Cavallo s.r.l. and its President Sergio Tramontano as the exclusive agent for Europe of the MSK Kinesis equipment and treatment protocols for vetinary medicine,
On May 24, 2022, HMNU signed an agreement with Prof. Dr. Francesco Braconaro, Dr Orthopedic, Medical Director Maugeri Group-ICS, Milano, Italy; President Medical Board HMNU MEDICAL and Physician for National Team of Italy to market the sports medicine equipment from HMNU-MSK Kinesis. Also on May 24, 2022, HMNU Signed an agreement with Dr. Amir Ghazy Mir Saeid, Milano Physiotherapy Doctor, Specialist in sport medicine and traumatology. Dr. Saied has been appointed as the exclusive Italian Representative for HMNU Medical sport departments in Italy.
The three entities have agreed to an annual sales of 900 HMNU MSK Kinesis medical machines at a minimum cost of 39,000 USD each for a minimum annual revenue in excess of Thirty Million USD.
These agreements were finalized with the Human Unitec launch of its new generation of its medical and wellness equipment designed for use in the European market. The design of this new line is the result of our MSK Kinesis teams years of study and from the successful treatments on patients for treatment of Parkinson diseases, prevention of blood clots and thrombosis dysfunctions. The equipment is made with ABS and Environmental Protection materials. The HMNU/MSK equipment has been EU and CE tested and approved for wellness, medical, sports and veterinary use.
For More on HMNU Subscribe Right Now!
HMNU is rocketing up the charts after the Company reported three strategic marketing agreements for its HMNU-MSK Kinesis Medical Equipment. The three entities have agreed to an annual sales of 900 HMNU MSK Kinesis medical machines at a minimum cost of 39,000 USD each for a minimum annual revenue in excess of $30 million USD. As we stated, HMNU has a super low float with just 881,930,000 shares outstanding, 489,246,567 of which are restricted leaving just 392,683,433 free trading shares worth under $2 million at current market levels. Currently HMNU is under heavy accumulation as penny stock speculators bid up the price with an eye on $0.055 recent highs. We will be updating on HMNU when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with HMNU.
Disclosure: we hold no position in HMNU either long or short and we have not been compensated for this article.